Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy

Abstract

Get full access to this article

View all access options for this article.

References

Tremlett HL , Oger J. Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis . J Neurol 2004; 251: 1297-303.

Byrnes V. , Afdhal N. , Challies T. , Greenstein PE Drug induced liver injury secondary to interferon-beta in multiple sclerosis . Ann Hepatol 2006; 5: 56-9.

Christopher V. , Scolding N. , Przemioslo RT Acute hepatitis secondary to interferon beta-1a in multiple sclerosis. J Neurol 2005; 252: 855-56.

Francis GS , Grumser Y. , Alteri E. , et al. Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance. Drug Safety 2003; 26: 815-27.

Pietrosi G. , Mandala L. , Vizzini GB , et al. Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination? Transpl Int 2008; 21: 502-04.

Yoshida EM , Rasmussen SL , Steinbrecher UP , et al. Fulminant liver failure during interferon beta treatment of multiple sclerosis. Neurology 2001; 56: 1416.

Lewis JH Hepatic toxicity of nonsteroidal antiinflammatory drugs. Drug Rev 1984; 3: 128-38.

Pulicken M. , Koteish A. , DeBusk K. , Calabresi PA Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy. Neurology 2006; 66: 1954-55.

Neumann H. , Csepregi A. , Sailer M. , Malfertheiner P. Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis. J Neurol 2007; 254: 816-7.

10.

von Kalckreuth V. , Lohser AW , Schramm C. Unmasking autoimmune hepatitis under immunomodulatory treatment of multiple sclerosis - not only beta interferon. Am J Gastroenterol 2008; 103: 2147-48.

11.

de Seze J. , Canva-Delcambre V. , Fajardy I. , et al. Autoimmune hepatitis and multiple sclerosis: a coincidental association? Mult Scler 2005; 11: 691-3.